|
Market Closed -
Nasdaq
00:00:00 05/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 2.800 USD | +0.72% |
|
-4.44% | +71.78% |
| 08-13 | Ovid Therapeutics Reports Pipeline and Business Updates | CI |
| 08-13 | Ovid Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 543M | - | - | - | ||
| 69.02B | |||||
| 66.32B | |||||
| 27.66B | - | ||||
| 25.84B | - | ||||
| 26.54B |
Select your edition
All financial news and data tailored to specific country editions
